31 results on '"Gkirkas, Konstantinos"'
Search Results
2. EASIX and m-EASIX predict severe cytokine release syndrome and overall survival after CAR T-cell therapy
3. Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation
4. Deformation Analysis of Myocardial Layers Detects Early Cardiac Dysfunction after Chemotherapy in Bone Marrow Transplantation Patients: A Continuous and Additive Cardiotoxicity Process
5. Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor
6. Thrombocytopenia in critically ill patients with severe sepsis/septic shock: Prognostic value and association with a distinct serum cytokine profile
7. Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison
8. Isolated extramedullary leukemic involvement of the heart presenting as fulminant heart failure
9. Solid tumor transmission from donor to recipient after allogeneic stem cell transplantation: it is rare but it happens!
10. Allogeneic Stem Cell Transplantation with a Novel Reduced Intensity Conditioning Regimen for the Treatment of Patients with Primary Cutaneous T-cell Lymphomas
11. Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute Leukemia
12. Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation
13. Extramedullary leukemia relapse after allogeneic stem cell transplantation: a novel mechanism of immune escape?
14. Oral Ribavirin with or without the Addition of Immune Globulin for the Treatment of Lower Respiratory Tract Infections Due to Respiratory Syncytial Virus or Parainfluenza in Patients after Allogeneic Stem Cell Transplantation
15. Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis
16. Oral Ribavirin with or without the Addition of Immune Globulin for the Treatment of Lower Respiratory Tract Infections Due to Respiratory Syncytial Virus or Parainfluenza in Patients after Allogeneic Stem Cell Transplantation
17. Coexistence of Myeloid and Lymphoid Neoplasms: A Single-Center Experience
18. Low-Dose Cotrimoxazole Administered in Hematopoietic Stem Cell Transplant Recipients as Prophylaxis for Pneumocystis jirovecii Pneumonia Is Effective in Prevention of Infection due to Nocardia
19. Natural killer cell cytotoxicity is a predictor of outcome for patients with high risk myelodysplastic syndrome and oligoblastic acute myeloid leukemia treated with azacytidine
20. Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis
21. Low Dose Alemtuzumab without Methotrexate for Gvhd Prevention
22. Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience
23. Balanced control of both hyper and hypo-inflammatory phases as a new treatment paradigm in sepsis
24. Low Dose Alemtuzumab without Methotrexate for Gvhd Prevention
25. Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.
26. Strategies for Improving the Efficacy of Donor Lymphocyte Infusion Following Stem Cell Transplantation
27. Natural Killer Cell Cytotoxicity Is a Predictor of Outcome for Patients with High Risk Myelodysplastic Syndrome and Oligoblastic Acute Myeloid Leukemia Treated with Azacytidine
28. Greek Registry of Myelofibrosis: Baseline Characteristics and Therapeutic Strategy
29. Serum Cytokine Profile in Patients with Septic Shock/Severe Sepsis and Thrombocytopenia
30. Strategies for improving the efficacy of donor lymphocyte infusion following stem cell transplantation.
31. Solid tumor transmission from donor to recipient after allogeneic stem cell transplantation: it is rare but it happens!
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.